Sinsin Pharmaceutical

신신제약 · 002800

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$52.8M (₩72.9B)

Overview

Sinsin Pharmaceutical makes over-the-counter pain-relief patches, adhesive medicated plasters worn on the skin to ease muscle, joint, and nerve pain, along with liquid and spray formats, insect-repellent products, corn-removal treatments, ointments, and bandages.

Listed on KOSDAQ, Korea's small-cap board, it supplies pharmacies and wholesale drug distributors, with pharmacies accounting for the largest share of its revenue. Patch and fever-reducing patch products are also shipped to markets across Southeast Asia, broader Asia, and Europe.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$82.4M
▲ +7.0% YoY
Operating profit · FY2025
US$7.8M
▲ +56.6% YoY
Net income · FY2025
US$6.7M
▲ +92.9% YoY

Revenue

  • FY2023US$74.3M
  • FY2024US$77.1M
  • FY2025US$82.4M

Operating profit

  • FY2023US$4.4M
  • FY2024US$5M
  • FY2025US$7.8M

Net income

  • FY2023US$3.4M
  • FY2024US$3.5M
  • FY2025US$6.7M

Key ratios (FY2025)

ROE
12.5%
Debt/Eq
84.5%
Op. margin
9.5%
Net margin
8.2%
Rev. YoY
▲ +7.0%

Why it matters

The company operates sales branches in major cities nationwide and maintains direct trading relationships with tens of thousands of retail pharmacies across Korea.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.